TuHURA Biosciences HURA
NASDAQ HURA
$1.39 -0.13 (-8.55%)
As of: Nov 12, 2026 · 10:19 AM EST

TuHURA Biosciences (HURA) Return on Equity [ROE] (2011 - 2026)

Updated

TuHURA Biosciences' Return on Equity [ROE] was -378.54% in Q1 2011.

Analysis

TuHURA Biosciences (HURA) Return on Equity [ROE] (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 TuHURA Biosciences 96.16 Mn 82.54 Mn - -152,536.17%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -152,536.17%
Mar 31, 2026 -144,131.71%
Dec 31, 2025 -168,635.30%
Sep 30, 2025 -160.67%
Jun 30, 2025 -186.19%
Mar 31, 2025 -182.33%
Jun 30, 2015 2,198.45%
Mar 31, 2015 438.73%
Dec 31, 2014 495.78%
Sep 30, 2011 -332.67%
Jun 30, 2011 -0.38%
Mar 31, 2011 -0.31%
API Access

TuHURA Biosciences Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=HURA&period=max&api_key=YOUR_API_KEY